Skip to main content

Day: January 6, 2021

WPD Pharmaceuticals to Collaborate With IAG to Deploy Artificial Intelligence and Quantitative Imaging to Assess the Effects of Berubicin

VANCOUVER, British Columbia, Jan. 06, 2021 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical-stage pharmaceutical company, is pleased to announce that it has engaged Image Analysis Group (“IAG”), a leading medical imaging company, to provide important critical imaging services during the Berubicin phase 2 clinical trials which are scheduled to start in February 2021.IAG has deep expertise in partnering with global biotech companies to provide centralized reading and analysis of patient responses in real time. IAG’s scientific and clinical imaging expertise in the field of glioblastoma multiforme (“GBM”), coupled with IAG’s proprietary Artificial Intelligence (AI) powered platform DYNAMIKA will allow WPD and its partners to review efficacy assessments, objective responses, and...

Continue reading

Pacira BioSciences to Present at the 39th Annual J.P. Morgan Healthcare Conference

PARSIPPANY, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 39th Annual J.P. Morgan Healthcare Conference at 7:30 AM ET on Wednesday, January 13, 2021. Live audio of the virtual event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.About Pacira         Pacira BioSciences, Inc. (NASDAQ: PCRX) is the leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL...

Continue reading

Kura Oncology to Present at J.P. Morgan Healthcare Conference

SAN DIEGO, Jan. 06, 2021 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation at the 39th Annual J.P. Morgan Healthcare Conference. Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to present an overview of the company on Tuesday, January 12, 2021 at 1:30 p.m. PT / 4:30 p.m. ET. The virtual conference will be held from January 11-14, 2021.A live audio webcast of the presentation will be available in the Investors section of Kura’s website at www.kuraoncology.com, with an archived replay available for 30 days following the event.About Kura OncologyKura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise...

Continue reading

Solid Biosciences to Present at 39th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced that Ilan Ganot, Chief Executive Officer, President and Co-Founder, will present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021 at 8:20 am ET. Following the prepared remarks, several members of the leadership team will be available for Q&A.Institutional investors interested in meeting with management during the conference may reach out to their J.P. Morgan representative.A live webcast of the presentation will be available on the Events page of the Investors section of the Company website or by clicking here. A webcast replay will be archived for approximately 30 days on the Events...

Continue reading

Goliath Significantly Expands Golddigger Claim Holdings Around Surebet High-Grade Gold-Silver Discovery, Golden Triangle B.C.

ADOPTION OF SHAREHOLDER RIGHTS PLANTORONTO, Jan. 06, 2021 (GLOBE NEWSWIRE) — Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) (Frankfurt: B4IF) (the “Company” or “Goliath”) is pleased to announce the extensive expansion of its claim holdings by 28% based on significant results that cover additional key geologic terrane around its Surebet high-grade polymetallic gold-silver discovery on its 100% controlled Golddigger property in the Golden Triangle, British Columbia.In addition, the Company has adopted a shareholder rights plan (the “Rights Plan”). The purpose of the Rights Plan is to provide protection for the shareholders and Board of Directors with adequate time to consider and evaluate any unsolicited bid and to provide the Board of Directors with adequate time to identify, develop and negotiate value-enhancing alternatives,...

Continue reading

Erdene Announces New Gold Discovery 3.5 km North of the Bayan Khundii Gold Deposit

HALIFAX, Nova Scotia, Jan. 06, 2021 (GLOBE NEWSWIRE) — Erdene Resource Development Corporation (TSX:ERD | MSE:ERDN) (“Erdene” or the “Company”) is pleased to provide exploration drilling results from its Dark Horse gold prospect.Highlights1:New high-grade, shallow, gold discovery hosted in a 4 kilometre long structure in the western portion of Dark Horse demonstrates potential for significant gold discoveries near the Bayan Khundii deposit:°  AAD-58 returned 45 metres of 5.97 g/t gold beginning at 10 metres down-hole, including 1 metre of 82.5 g/t gold within 8 metres of 27.1 g/t gold°  AAD-57, located 180 metres north of AAD-58, returned 16 metres of 0.6 g/t gold beginning at 52 metres down-hole, and 48 metres of 1.2 g/t gold beginning at 194 metres down-hole, including 30 metres of 1.7 g/t gold°  AAD-51, collared 1 kilometre north...

Continue reading

Thryv, Inc. to expand international footprint with intent to acquire Australia’s Sensis Holdings

Dallas, Jan. 06, 2021 (GLOBE NEWSWIRE) — Thryv Holdings, Inc. (NASDAQ:THRY), the provider of Thryv® software, the end-to-end client experience platform for small businesses, today announced it is in discussions to acquire Sensis Holding Limited, Australia’s leading provider of marketing solutions serving small to medium-sized businesses (SMBs).“Sensis represents an extraordinary international expansion opportunity,” said Thryv CEO and President Joe Walsh. “Sensis is a highly respected national player that has long helped Australia’s small businesses to market themselves successfully.”The acquisition will allow Australia’s entrepreneurs to run their businesses smarter by using Thryv.  Australia is experiencing a digital revolution and SMBs are embracing tools to adapt to a rapidly changing landscape. Australia boasts 2.3 million SMBs,...

Continue reading

OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021

ROCHESTER, Mich., Jan. 06, 2021 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to present at H.C. Wainwright’s BioConnect Conference being held virtually on January 11-14, 2021.The company’s presentation will be available on-demand via the H.C. Wainwright conference portal here and in the investor relations section at investors.optimizerx.com beginning at 6:00 a.m. Eastern time on Monday, January 11.OptimizeRx CEO, William Febbo, will participate in virtual one-on-one meetings with institutional analysts and investors throughout the conference.Management will discuss the company’s expanding addressable market due to the launch of new digital health solutions, and how an increasing number of enterprise-level,...

Continue reading

The Simply Good Foods Company Reports Fiscal First Quarter 2021 Financial Results; Updates Fiscal First Half of Year 2021 Outlook

DENVER, Jan. 06, 2021 (GLOBE NEWSWIRE) — The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today reported financial results for the thirteen weeks ended November 28, 2020. Year ago amounts for the first quarter ended November 30, 2019 represents thirteen weeks of legacy Atkins and approximately three weeks of Quest Nutrition, LLC (“Quest”). The Company’s references to “legacy Atkins” in this press release encompasses Simply Goods Foods’ business excluding Quest.Highlights:(1)Net sales increased 51.9% driven by the Quest acquisitionNet income of $22.5 million versus a net loss of $4.8 millionEarnings (loss) per diluted share (“EPS”) of $0.23 versus $(0.05)Adjusted Diluted EPS (3)of $0.29 versus $0.22Adjusted EBITDA(2)increased...

Continue reading

Marlin Spring Acquires Office Building in Ottawa

OTTAWA, Jan. 06, 2021 (GLOBE NEWSWIRE) — Marlin Spring in partnership with Colonnade BridgePort, is pleased to announce the successful acquisition of a 12-storey office building located at 81 Metcalfe Street in Ottawa, Ontario.Prominently located at the corner of Slater and Metcalfe streets in the heart of Ottawa’s Central Business District, the office building is leased to a diverse roster of tenants in government, health care and professional services, including a ground-level Starbucks. It features premium on-site amenities such as conference and shower facilities, is ideally situated among a plethora of nearby urban amenities and just next to Ottawa’s new Light Rail Transit Confederation Line.“We are very pleased to add this important acquisition to our growing portfolio of income-producing assets”, said Ashi Mathur, President...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.